In vitro mechanisms involved in the regulation of cell survival by lithium chloride and IGF-1 in human hormone-dependent breast cancer cells (MCF-7)

Toxicology Letters

Volumn 214, Issue 2, 2012, Pages 182-191

  Suganthi, Muralidharan ^a   Sangeetha, Gopalakrishnan ^a   Benson, Chellakan Selvanesan ^a   Babu, Somasundaram Dinesh ^a   Sathyavathy, Anandhan ^a   Ramadoss, Sivakumar ^b   Ravi Sankar, Bhaskaran ^a  

^a UNIVERSITY OF MADRAS   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; GSK 3 ; IGF 1; Lithium chloride

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PROTEIN KINASE B; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; DNA REPAIR; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELL SURVIVAL; CHROMONES; ENZYME INHIBITORS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; LITHIUM CHLORIDE; MCF-7 CELLS; MORPHOLINES; NEOPLASMS, HORMONE-DEPENDENT; ORGANIC CHEMICALS; SIGNAL TRANSDUCTION;

EID: 84866498648     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.08.022     Document Type: Article

References (55)

1. Adams J.M., Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Current Opinion in Immunology 2007, 19(5):488-496. 10.1016/j.coi.2007.05.004.
2. Alle K.M., Henshall S.M., Field A.S., Sutherland R.L. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1998, 4(4):847-854.
3. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(15):8745-8750.
4. Chen C.L., Lin C.F., Chiang C.W., Jan M.S., Lin Y.S. Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis. Molecular Pharmacology 2006, 70(2):510-517. 10.1124/mol.106.024059.
5. Chen H., Yan G.C., Gishizky M.L. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. Cell Growth & Differentiation: The Molecular Biology Journal of the American Association for Cancer Research 1998, 9(11):939-947.
6. Chrysis D., Calikoglu A.S., Ye P., D'Ercole A.J. Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21(5):1481-1489.
7. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Annals of the New York Academy of Sciences 2005, 1053:195-204. 10.1196/annals.1344.018.
8. Cohen P., Frame S. The renaissance of GSK3. Nature Reviews Molecular Cell Biology 2001, 2(10):769-776. 10.1038/35096075.
9. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378(6559):785-789. 10.1038/378785a0.
10. Dantzer F., Nasheuer H.P., Vonesch J.L., de Murcia G., Menissier-de Murcia J. Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic Acids Research 1998, 26(8):1891-1898.
11. Davidson N.E., Gelmann E.P., Lippman M.E., Dickson R.B. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Molecular Endocrinology 1987, 1(3):216-223.
12. Desbois-Mouthon C., Cadoret A., Blivet-Van Eggelpoel M.J., et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 2001, 20(2):252-259. 10.1038/sj.onc.1204064.
13. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. Journal of Cell Science 2003, 116(Pt 7):1175-1186.
14. Erdal E., Ozturk N., Cagatay T., Eksioglu-Demiralp E., Ozturk M. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. International Journal of Cancer Journal International Du Cancer 2005, 115(6):903-910. 10.1002/ijc.20972.
15. Fernet M., Ponette V., Deniaud-Alexandre E., et al. Poly(ADP-ribose) polymerase, a major determinant of early cell response to ionizing radiation. International Journal of Radiation Biology 2000, 76(12):1621-1629.
16. Germain D., Russell A., Thompson A., Hendley J. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. The Journal of Biological Chemistry 2000, 275(16):12074-12079.
17. Gould T.D. Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilizing medications. Expert Opinion on Therapeutic Targets 2006, 10:377-392.
18. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. Journal of Neurochemistry 2001, 78(6):1219-1232.
19. Harwood A.J. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Molecular psychiatry 2005, 10:117-126.
20. Jope R.S., Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004, 29(2):95-102. 10.1016/j.tibs.2003.12.004.
21. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Experimental Cell Research 1999, 253(1):210-229. 10.1006/excr.1999.4690.
22. Kang H.J., Noh J.S., Bae Y.S., Gwag B.J. Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cgamma. Molecular Pharmacology 2003, 64(2):228-234. 10.1124/mol.64.2.228.
23. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(16):8455-8459.
24. Kulikov R., Boehme K.A., Blattner C. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Molecular and Cellular Biology 2005, 25(16):7170-7180. 10.1128/MCB.25.16.7170-7180.2005.
25. Laban C., Bustin S.A., Jenkins P.J. The GH-IGF-I axis and breast cancer. Trends in Endocrinology and Metabolism 2003, 14:28-34.
26. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Molecular and Cellular Biology 1998, 18(6):3563-3571.
27. Michael D., Oren M. The p53 and Mdm2 families in cancer. Current Opinion in Genetics and Development 2002, 12(1):53-59.
28. Minshall C., Arkins S., Straza J., et al. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. Journal of Immunology 1997, 159(3):1225-1232.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
30. Mu Z., Hachem P., Agrawal S., Pollack A. Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination. International Journal of Radiation Oncology, Biology, Physics 2004, 58(2):336-343.
31. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling 2002, 14(5):381-395.
32. Playford M.P., Bicknell D., Bodmer W.F., Macaulay V.M. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(22):12103-12108. 10.1073/pnas.210394297.
33. Rao A.S., Kremenevskaja N., Resch J., Brabant G. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. European Journal of Endocrinology/European Federation of Endocrine Societies 2005, 153(6):929-938. 10.1530/eje.1.02038.
34. Ren X., Meng F., Yin J., et al. Action mechanisms of lithium chloride on cell infection by transmissible gastroenteritis coronavirus. PloS ONE 2011, 6(5):e18669. 10.1371/journal.pone.0018669.
35. Repetto M.R., Repetto M. Concentrations in human fluids: 101 drugs affecting the digestive system and metabolism. Journal of Toxicology and Clinical Toxicology 1999, 37(1):1-9.
36. Rice A.M., Sartorelli A.C. Inhibition of 20S and 26S proteasome activity by lithium chloride: impact on the differentiation of leukemia cells by all-trans retinoic acid. The Journal of Biological Chemistry 2001, 276(46):42722-42727. 10.1074/jbc.M106583200.
37. Sahebgharani M., Nejati M., Sepehrizadeh Z., et al. Lithium chloride protects PC12 pheochromocytoma cell line from morphine-induced apoptosis. Archives of Iranian Medicine 2008, 11(6):639-648.
38. Shai L.J., Abotsi E.K., Tyobekai E.M., Wachira J.M. Partial involvement of c-jun protooncogene in growth enhancing and cytotoxic effects of lithium in vitro. Cellular and Molecular Biology (Noisy-le-grand) 2003, 49(7):1137-1143.
39. Shakoori A., Ougolkov A., Yu Z.W., et al. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochemical and Biophysical Research Communications 2005, 334(4):1365-1373. 10.1016/j.bbrc.2005.07.041.
40. Sinha D., Bannergee S., Schwartz J.H., Lieberthal W., Levine J.S. Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. The Journal of Biological Chemistry 2004, 279(12):10962-10972. 10.1074/jbc.M312048200.
41. Sinha D., Wang Z., Ruchalski K.L., et al. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. American Journal of Physiology Renal Physiology 2005, 288(4):F703-F713. 10.1152/ajprenal.00189.2004.
42. Song L., Zhou T., Jope R.S. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neuroscience 2004, 5:20. 10.1186/1471-2202-5-20.
43. Takahashi-Yanaga F., Sasaguri T. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cellular Signalling 2008, 20(4):581-589. 10.1016/j.cellsig.2007.10.018.
44. Tan J., Zhuang L., Leong H.S., Iyer N.G., Liu E.T., Yu Q. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Research 2005, 65(19):9012-9020. 10.1158/0008-5472.CAN-05-1226.
45. Tang H.R., He Q. Effects of lithium chloride on the proliferation and apoptosis of K562 leukemia cells. Bulletin of Hunan Medical University 2003, 28(4):357-360.
46. Tseng W.P., Lin-Shiau S.Y. Long-term lithium treatment prevents neurotoxic effects of beta-bungarotoxin in primary cultured neurons. Journal of Neuroscience Research 2002, 69(5):633-641. 10.1002/jnr.10318.
47. Turenne G.A., Price B.D. Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity. BMC Cell Biology 2001, 2:12.
48. Tyobeka E.M., Becker R.W. Growth and morphological changes induced by lithium chloride treatment of HL-60 cells. Cell Biology International Reports 1990, 14(8):667-679.
49. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Reviews Cancer 2002, 2(7):489-501. 10.1038/nrc839.
50. Wang H., Nan L., Yu D., Agrawal S., Zhang R. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2001, 7(11):3613-3624.
51. Watcharasit P., Bijur G.N., Zmijewski J.W., et al. Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(12):7951-7955. 10.1073/pnas.122062299.
52. Welshons W.V., Engler K.S., Taylor J.A., Grady L.H., Curran E.M. Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. Journal of Cellular Physiology 1995, 165(1):134-144. 10.1002/jcp.1041650116.
53. Zhang W.V., Jullig M., Connolly A.R., Stott N.S. Early gene response in lithium chloride induced apoptosis. Apoptosis: An International Journal on Programmed Cell Death 2005, 10(1):75-90. 10.1007/s10495-005-6063-x.
54. Zou Y., Ewton D.Z., Deng X., Mercer S.E., Friedman E. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. The Journal of Biological Chemistry 2004, 279(26):27790-27798. 10.1074/jbc.M403042200.
55. Zwijsen R.M., Klompmaker R., Wientjens E.B., Kristel P.M., van der Burg B., Michalides R.J. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Molecular and Cellular Biology 1996, 16(6):2554-2560.